Dynamics of prostacyclin and thromboxane during myocardial ischemia. 1989

E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
Department of Experimental Surgery, University of Medicine, Pécs, Hungary.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1

Related Publications

E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
August 1991, Kardiologiia,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
March 2003, Prostaglandins, leukotrienes, and essential fatty acids,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
August 1991, Prostaglandins, leukotrienes, and essential fatty acids,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
April 1986, Neurology,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
January 1988, Sovetskaia meditsina,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
March 1988, Kardiologiia,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
January 1983, Acta obstetricia et gynecologica Scandinavica. Supplement,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
July 1986, Circulation research,
E Röth, and D Kelemen, and B Török, and A Nagy, and S Pollak
January 1985, Kyobu geka. The Japanese journal of thoracic surgery,
Copied contents to your clipboard!